Basics Nurix Therapeutics, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $798.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.69 | 3.52% Avg Daily Range (30 D): $0.30 | 3.26% Avg Daily Range (90 D): $0.30 | 2.89% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): .98M Avg Daily Volume (90 D): .75M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,724 Avg Inst. Trade: $1.99M Avg Inst. Trade (30 D): $1.78M Avg Inst. Trade (90 D): $1.53M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.82M Avg Closing Trade (30 D): $1.06M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 105.79K     News Oct 22, 2025 @ 10:00 AM Nurix Initiates DAYBreakâ„¢ Pivotal Study of B... Source: Nurix Therapeutics, Inc. Oct 18, 2025 @ 7:00 AM Nurix Therapeutics Reports New Clinical Data from ... Source: Nurix Therapeutics Jul 24, 2025 @ 5:00 PM Non-Hodgkin’s Lymphoma Market Forecast to S... Source: Delveinsight Jul 14, 2025 @ 5:00 PM Waldenstrom Macroglobulinemia Market Sees Surging ... Source: Delveinsight Jun 6, 2025 @ 11:00 AM Nurix Therapeutics to Host a Webcast Conference Ca... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.03 $-.52 Diluted EPS $-1.03 $-.52 Revenue $ $ 7.89M $ 44.06M Gross Profit $ $ $ Net Income / Loss $ $ -86.42M $ -43.46M Operating Income / Loss $ $ -91.39M $ -48.32M Cost of Revenue $ $ $ Net Cash Flow $ $ -5.76M $ 8.34M PE Ratio